Records endometrial cancer cases across Italian cancer centers
Collects clinical information on endometrial cancer patients treated at Italian centers.
Plain-language title generated from the registry record
Registry title: The Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population
Key facts
- Where
- Roma, ItalySee the site
Where in Italy
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSRoma, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Trial code
- NCT07558889
- Record updated
- 30 April 2026
- Original description
The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endometrial carcinoma diagnosed and treated in the reference oncology centers involved on the national territory, to create a process of analysis of the dataRead full original descriptionShow less
The ENDOCancer-DATA: the Surveillance, Epidemiology, and End Results Database Program on Endometrial Cancer in the Italian Population
The aim of this study is to lay the bases for an ambitious project that reports and records all the epidemiological-clinical information of the cases of endometrial carcinoma diagnosed and treated in the reference oncology centers involved on the national territory, to create a process of analysis of the data
Inclusion: diagnosis of endometrial cancer (stage I-IV, G1-3, and special histotypes); age > 18 years; American Society of Anesthesiologists classification (ASA score) 1-3; patients undergoing staging, cytoreduction or diagnostic surgery with acquisition of histological examination on which IHC and/or NGS studies have been performed for the molecular profile of the carcinoma; Signed informed consent.
Exclusion: patients with missing information; patients not treated in the participating centers for which only partial and fragmented information will be available; molecular profile not known and\or not recoverable and retrospectively analysable.